Kim, J.-E.; Lee, D.-S.; Park, H.; Kim, T.-H.; Kang, T.-C.
Inhibition of AKT/GSK3β/CREB Pathway Improves the Responsiveness to AMPA Receptor Antagonists by Regulating GRIA1 Surface Expression in Chronic Epilepsy Rats. Biomedicines 2021, 9, 425.
https://doi.org/10.3390/biomedicines9040425
AMA Style
Kim J-E, Lee D-S, Park H, Kim T-H, Kang T-C.
Inhibition of AKT/GSK3β/CREB Pathway Improves the Responsiveness to AMPA Receptor Antagonists by Regulating GRIA1 Surface Expression in Chronic Epilepsy Rats. Biomedicines. 2021; 9(4):425.
https://doi.org/10.3390/biomedicines9040425
Chicago/Turabian Style
Kim, Ji-Eun, Duk-Shin Lee, Hana Park, Tae-Hyun Kim, and Tae-Cheon Kang.
2021. "Inhibition of AKT/GSK3β/CREB Pathway Improves the Responsiveness to AMPA Receptor Antagonists by Regulating GRIA1 Surface Expression in Chronic Epilepsy Rats" Biomedicines 9, no. 4: 425.
https://doi.org/10.3390/biomedicines9040425
APA Style
Kim, J.-E., Lee, D.-S., Park, H., Kim, T.-H., & Kang, T.-C.
(2021). Inhibition of AKT/GSK3β/CREB Pathway Improves the Responsiveness to AMPA Receptor Antagonists by Regulating GRIA1 Surface Expression in Chronic Epilepsy Rats. Biomedicines, 9(4), 425.
https://doi.org/10.3390/biomedicines9040425